Abstract Objective To investigate the factors influencing the prognosis of patent ductus arteriosus (PDA) in very low birth weight (VLBW) infants. Methods A total of 194 VLBW infants who were admitted from January 2012 to December 2014 were enrolled as study subjects. According to cardiac ultrasound findings and treatment outcome, these infants were divided into non-PDA group, spontaneous closure group, pharmaceutical closure group, and surgical closure group. Their clinical and echocardiographic characteristics were analyzed. Results The spontaneous closure rate of PDA was 58.7%. The spontaneous closure group showed significantly higher gestational age, birth weight, and proportion of small-for-gestational-age infants than the pharmaceutical and surgical closure groups (P < 0.05). The pharmaceutical and surgical closure groups had a significantly higher incidence rate of neonatal respiratory distress syndrome and a significantly higher proportion of infants who were given pulmonary surfactant (PS) than the spontaneous closure group (P < 0.05). During different periods of time, the spontaneous closure group had a significantly smaller ductus arteriosus diameter than the pharmaceutical and surgical closure groups (P < 0.05). The multivariate logistic regression analysis showed that gestational age, application of PS, and ductus arteriosus diameter at 48 hours were significantly associated with the prognosis of PDA. The major transductal flow pattern in the spontaneous closure group was closing pattern, while in the pharmaceutical and surgical closure groups, the main flow patterns were pulmonary hypertension and growing patterns within 48 hours and growing pattern on days 4 and 7. Conclusions The VLBW infants have a high spontaneous closure rate of PDA. A decreased closure rate of PDA is associated with the lower gestational age and the application of PS. PDA with a large ductus arteriosus diameter and a growing or pulsatile flow pattern cannot easily achieve spontaneous closure.
WANG Chen-Hong,SHI Li-Ping,MA Xiao-Lu et al. Factors influencing the prognosis of patent ductus arteriosus in very low birth weight infants[J]. CJCP, 2016, 18(8): 688-693.
WANG Chen-Hong,SHI Li-Ping,MA Xiao-Lu et al. Factors influencing the prognosis of patent ductus arteriosus in very low birth weight infants[J]. CJCP, 2016, 18(8): 688-693.
Kabra NS,Schmidt B,Roberts RS,et al.Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants:results from the Trial of Indomethacin Prophylaxis in Preterms[J].J Pediatr,2007,150(3):229-234.
[15]
Rolland A,Shankar-Aguilera S,Diomandé D,et al.Natural evolution of patent ductus arteriosus in the extremely preterm infant[J].Arch Dis Child Fetal Neonatal Ed,2015,100(1):F55-F58.
[16]
Herrman K,Bose C,Lewis K,et al.Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit[J].Arch Dis Child Fetal Neonatal Ed,2009,94(1):F48-F50.
[2]
Sharman R,Sullivan K,Young R,et al.Executive function in adolescents with PKU and their siblings:Associations with biochemistry[J].Mol Genet Metab Rep,2015,4:87-88.
Jahja R,Huijbregts SC,de Sonneville LM.Mental health and social functioning in early treated Phenylketonuria:the PKU-COBESO study[J].Mol Genet Metab,2013,110(Suppl):S57-S61.
McPherson C,Gal P,Ransom JL,et al.Indomethacin pharmacodynamics are altered by surfactant:a possible challenge to current indomethacin dosing guidelines created before surfactant availability[J].Pediatr Cardiol,2010,31(4):505-510.
[20]
El Hajjar M,Vaksmann G,Rakza T,et al.Severity of the ductal shunt:a comparison of different markers[J].Arch Dis Child Fetal Neonatal Ed,2005,90(5):F419-F422.
[21]
McNamara PJ,Sehgal A.Towards rational management of the patent ductus arteriosus:the need for disease staging[J].Arch Dis Child Fetal Neonatal Ed,2007,92(6):F424-F427.
[22]
Su BH,Watanabe T,Shimizu M,et al.Echocardiographic assessment of patent ductus arteriosus shunt flow pattern in premature infants[J].Arch Dis Child Fetal Neonatal Ed,1997,77(1):F36-F40.